Dr. Reddy's launches Sildenafil tablets in US

The launch followed the USFDA approval for the company’s Sildenafil tablets.

 

Mumbai, November 19, 2012: The Indian pharma firm Dr Reddy’s has announced the launch of Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

 

It should be noted here that this followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, as per a statement from the company.

 

As per the IMS Health data, the Revatio brand had US sales of approximately $338.67 million for the most recent twelve months ending September 2012.

 

Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes.

Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...